Middletown, DE -- (SBWIRE) -- 08/30/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Agilent Technologies Inc.(NYSE:A), ABB Ltd (ADR)(NYSE:ABB), AbbVie Inc(NYSE:ABBV), Abbott Laboratories(NYSE:ABT)
Agilent Technologies Inc.(NYSE:A) opened the session at $46.63, remained amid the day range of $46.42 - $47.03, and closed the session at $46.80. The stock showed a positive performance of +0.13% in previous trading session. The stock gained a volume of 1.90 million shares and the average volume of the stock remained 2.31 million shares. Agilent Technologies, Inc. (Agilent) is a measurement company providing bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. During the fiscal year ended October 31, 2011 (fiscal 2011), it had three business segments: electronic measurement business, chemical analysis business and life sciences business.
Why Should Investors Buy A After The Recent Gain? Just Go Here and Find Out
ABB Ltd (ADR)(NYSE:ABB) traded with volume of 2.30 million shares in the prior session and the average volume of the stock remained 1.06 million shares. The 52 week range of the stock remained $17.04 - $23.37. The stock showed a negative movement of -1.32% and closed its session at $21.61. The market capitalization of the stock remained 49.63 billion. ABB Ltd (ABB) is engaged in power and automation technologies committed to improving performance and lowering the environmental impact for utility and industry customers. The Company provides a broad range of products, systems, solutions and services that are designed to power grid reliability boost industrial productivity and enhance energy efficiency.
Why Should Investors Buy ABB After the Recent Fall? Just Go Here and Find Out
AbbVie Inc(NYSE:ABBV) exchanged 2.79 million shares and the average volume remained 3.76 million shares. The stock escalated +0.14% and closed the session at $42.62. The EPS of the stock remained 3.25. The shares outstanding of the stock remained 1.59 billion. AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. The Company discovers, develops, and commercializes advanced therapies. AbbVie's portfolio of products include a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products.
For How Long ABBV will fight for Profitability? Read This Trend Analysis report
Abbott Laboratories (NYSE:ABT) gained volume of 5.68 million shares, while the average volume remained 6.21 million shares. The stock decreased -0.06% and finished the session Thursday at $33.73. The EPS of the stock remained 0.53. The one month of the stock was -8.19% and three month trend remained negative -10.58%. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals.
Has ABT Found The Bottom and Ready To Move Up? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)